TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients
Anna A. Brożyna; Huazhang Guo; Sun‐Eun Yang; Lynn Cornelius; Gerald Linette; Michael Murphy; Christine Sheehan; Jeffrey Ross; Andrzej Slominski; J. Andrew Carlson
Author Information: Department of Tumor Pathology and Pathomorphology, Oncology Centre—Prof. Franciszek Łukaszczyk Memorial Hospital, Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.